These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25376442)

  • 1. Revisiting antifungal prophylaxis in high-risk liver transplant recipients.
    Huprikar S
    Am J Transplant; 2014 Dec; 14(12):2683-4. PubMed ID: 25376442
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
    Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
    Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
    Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
    Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Prophylaxis in Liver Transplant Recipients.
    Winston DJ; Busuttil RW; Singh N
    Clin Infect Dis; 2015 Oct; 61(8):1349-50. PubMed ID: 26261207
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis.
    Evans JD; Morris PJ; Knight SR
    Am J Transplant; 2014 Dec; 14(12):2765-76. PubMed ID: 25395336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
    Lingegowda PB; Tan CK; Tan AL; Tan BH
    Ann Acad Med Singap; 2011 Jun; 40(6):287-90. PubMed ID: 21779617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Eur J Clin Microbiol Infect Dis; 2006 Sep; 25(9):549-61. PubMed ID: 16912905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole prophylaxis for high-risk liver transplant recipients.
    Kung N; Fisher N; Gunson B; Hastings M; Mutimer D
    Lancet; 1995 May; 345(8959):1234-5. PubMed ID: 7739317
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
    Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Winston et al.
    Saliba F; Fischer L
    Clin Infect Dis; 2015 Oct; 61(8):1350-1. PubMed ID: 26261208
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
    Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W
    Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
    Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
    Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
    Sun HY; Cacciarelli TV; Singh N
    Transplantation; 2013 Sep; 96(6):573-8. PubMed ID: 23842191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal management practices in liver transplant recipients.
    Singh N; Wagener MM; Cacciarelli TV; Levitsky J
    Am J Transplant; 2008 Feb; 8(2):426-31. PubMed ID: 18190655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
    Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
    Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.